非肝硬化性门脉高压的临床诊断

doi:10.3969/j.issn.1672-5069.2022.01.001

Abstract

He Fuliang, Ma Lin, Li Yuerong, et al. Non-cirrhotic portal hypertension:the highlight of its diagnosis[J]. Journal of Practical Hepatology, 2022, 25(1): 1-4.

[1] Turco L, Garcia-Tsao G. Portal hypertension: Pathogenesis and diagnosis. Clin Liver Dis,2019,23(4):573-587.
[2] 周慧,冯晓宁,任浩,等.非肝硬化门脉高压患者临床特点分析. 实用肝脏病杂志. 2021,24(3): 415-418.
[3] Khanna R, Sarin SK. Noncirrhotic portal hypertension: Current and emerging perspectives. Clin Liver Dis, 2019,23(4):781-807.
[4] Alsomali MI, Yearsley MM, Levin DM, et al.Diagnosis of congenital hepatic fibrosis in adulthood. Am J Clin Pathol, 2020,153(1):119-125.
[5] 何福亮,齐瑞兆,张珂,等. 脾切除联合贲门周围血管离断术治疗特发性非硬化性门脉高压所致食管胃底静脉曲张破裂出血的疗效分析. 临床和实验医学杂志,2020,19(13): 1402-1406.
[6] Guido M, Alves VAF, Balabaud C, et al. International Liver Pathology Study Group. Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition. Histopathology,2019,74(2): 219-226.
[7] Zhuge Y, Liu Y, Xie W, et al. Chinese Society of Gastroenterology Committee of Hepatobiliary Disease. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. J Gastroenterol Hepatol, 2019,34(4):634-642.
[8] Corbacioglu S, Jabbour EJ, Mohty M. Risk factors for development of and progression of hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Biol Blood Marrow Transplant, 2019,25(7):1271-1280.
[9] Chan SS, Colecchia A, Duarte RF, et al. Imaging in hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Biol Blood Marrow Transplant, 2020,26(10):1770-1779.
[10] 中华医学会消化病学分会肝胆疾病协作组. 吡咯生物碱相关肝窦阻塞综合征诊断和治疗专家共识意见(2017年,南京). 临床肝胆病杂志, 2017,33(9): 1627-1637.
[11] 朱广昌,汪忠镐,卞策,等.布加综合征诊断与治疗的发展历程. 中国血管外科杂志(电子版),2017,9(1):4-10.
[12] Qi X, Guo X, Fan D. Difference in Budd-Chiari syndrome between the west and China. Hepatology,2015,62(2):656.
[13] Iliescu L, Toma L, Mercan-Stanciu A, et al. Budd-Chiari syndrome - various etiologies and imagistic findings. A pictorial review. Med Ultrason, 2019,21(3):344-348.
[14] 中国医师协会腔内血管学专业委员会腔静脉阻塞专家委员会. 布-加综合征亚型分型的专家共识. 临床肝胆病杂志,2017,33(7):1229-1235.
[15] 何福亮,王磊,赵洪伟,等.直接性肝内门腔分流术在布加综合征中的应用. 中华肝胆外科杂志,中华肝胆外科杂志,2021,27(1): 30-35.

Non-cirrhotic portal hypertension:the highlight of its diagnosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Yang Yan, Liu Ting, Dai Lin, et al. Noninvasive assessment of liver fibrosis via liver and spleen stiffness measurement using acoustic palpation elastography in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2022, 25(2): 183-186.
[2]	Qu Ying, Cai Xiaobo, Zhang Qidi, et al. Prevalence of serum anti-mitochondrial antibody-M2 antibody in health check-up individuals [J]. Journal of Practical Hepatology, 2022, 25(2): 203-206.
[3]	Zheng Xiaoqin, Xu Hui, Li Li, et al. Clinical features of patients with familial primary biliary cirrhosis [J]. Journal of Practical Hepatology, 2022, 25(2): 207-210.
[4]	Liu Songtao, Liu Mei, Qu Yachao, et al. Primary hepatic neuroendocrine neoplasm: An analysis of 4 cases and literature review [J]. Journal of Practical Hepatology, 2022, 25(2): 251-254.
[5]	Chen Jing, Zhu Yueyong. Non-invasive diagnosis of portal hypertension in patients with liver cirrhosis: serum markers or imaging? [J]. Journal of Practical Hepatology, 2022, 25(1): 9-12.
[6]	Ye Chao, Li Wenyuan, Li Lei, et al. Diagnostic value of percutaneous liver biopsy for patients with liver injury of unknown origin [J]. Journal of Practical Hepatology, 2022, 25(1): 38-41.
[7]	Tan Yuying, Zhang Xin, Zhang Juanzi, et al. Diagnostic value of MRI and serum GPC3 levels in patients with nodular regenerative hyperplasia [J]. Journal of Practical Hepatology, 2022, 25(1): 88-91.
[8]	Xiao Qian, Zhou Zhan, Hu Xiaoli. Clinical application of contrast-enhanced ultrasound parameters in the quantitative diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2022, 25(1): 92-95.
[9]	Chen Junguang, Deng Xiaofei, Lin Shujun, et al. Ultrasonographic features in patients with acute purulent cholecystitis [J]. Journal of Practical Hepatology, 2022, 25(1): 116-119.
[10]	Yang Fan, Wang Jian, Wen Zhi. Multi-slice spiral CT features of patients with gallbladder adenomyosis different from with gallbladder cancer [J]. Journal of Practical Hepatology, 2022, 25(1): 140-143.
[11]	Tang Lei, Zou Guizhou. Management of patients with biliary liver injury caused by surgical diseases [J]. Journal of Practical Hepatology, 2021, 24(6): 769-771.
[12]	Xing Li, Du Qianying, Jiang Yanli, et al. Impact of segmented injection of contrast agent on hepatic vein imaging by CT angiography in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(6): 871-874.
[13]	Wu Huijuan, He Nian'an, Xie Li, et al. Contrast-enhanced ultrasonography and serum CA19-9 levels in differential diagnosis of patients with intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2021, 24(6): 903-906.
[14]	Zhou Zheng, Liu Wei. Contrast-enhanced ultrasound features of hepatic hemangioma, hepatocellular carcinoma and hepatic angiomyolipoma [J]. Journal of Practical Hepatology, 2021, 24(6): 911-914.
[15]	Zhao Jianbo, Tan Qing. Non-cirrhotic portal hypertension: current state [J]. Journal of Practical Hepatology, 2021, 24(5): 613-616.